Related Experiment Videos
[Intracavernous injections in 1991]
1Clinique Urologique, Hôpital Cochin, Paris.
Journal D'Urologie
|January 1, 1991
Summary
Intracavernous injections are a reliable method for diagnosing and treating erectile dysfunction. Prostaglandin E1 shows high efficacy, though availability remains a challenge.
Area of Science:
- Urology
- Physiology
Context:
- Intracavernous injections have been utilized for approximately a decade for diagnosing and managing erectile dysfunction.
- Advancements in understanding erection physiology and the introduction of prostaglandin E1 have driven this development.
Purpose:
- To review the existing literature and clinical experience regarding intracavernous injections for erectile insufficiency.
- To evaluate the diagnostic and therapeutic utility of intracavernous injections.
Summary:
- Diagnostic intracavernous injections can effectively rule out vascular or cavernous causes of erectile dysfunction if a sustained erection is achieved.
- Intracavernous injections can treat all forms of erectile insufficiency, provided the induced erection enables penetration.
- Prostaglandin E1 demonstrates the highest response rates and fewest adverse effects among vasoactive agents, despite current availability limitations.
Impact:
- Provides a clear diagnostic criterion for erectile dysfunction based on injection response.
- Establishes intracavernous injections as a viable treatment option for various causes of erectile insufficiency.
- Highlights prostaglandin E1 as a promising therapeutic agent, while noting practical access issues.